Eplerenone + Placebo
Pre-clinicalCompleted 0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Hypoglycemia
Conditions
Hypoglycemia
Trial Timeline
Jan 1, 2011 → Aug 1, 2016
NCT ID
NCT01394627About Eplerenone + Placebo
Eplerenone + Placebo is a pre-clinical stage product being developed by Johnson & Johnson for Hypoglycemia. The current trial status is completed. This product is registered under clinical trial identifier NCT01394627. Target conditions include Hypoglycemia.
What happened to similar drugs?
2 of 14 similar drugs in Hypoglycemia were approved
Approved (2) Terminated (0) Active (12)
Hype Score Breakdown
Clinical
3
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01394627 | Pre-clinical | Completed |
Competing Products
20 competing products in Hypoglycemia